Minocycline
Spezifikationen
10118-90-8CAS-Nummer
(4S,4aS,5aR,12aR)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamideIUPAC-Name
C23H27N3O7Chemische Formel
457.5 g/molMolekulargewicht
minocycline; 10118-90-8; Minocyclin; Minociclina; Minomycin; Dynacin; Minocin; (4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE; Minocyn; 7-Dimethylamino-6-demethyl-6-deoxytetracycline; CL 59806; DTXSID1045033; FYY3R43WGO; Tri-minocycline; (4S,4aS,5aR,12aR)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide; 4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide; Minocyclinum; CHEBI:50694; NSC 141993; Minocyclinum [INN-Latin]; NCGC00183044-01; Borymycin; Minociclina [INN-Spanish]; MIY; MINO; minociclinum; Minocline; Minoz; Mino-Tabs; 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)-; HSDB 3130; NSC-141993; Minocin (Hydrochloride); Vectrin (Hydrochloride); UNII-FYY3R43WGO; Minocycline (USAN/INN); BRN 3077644; Lactoferrin B & Minocycline; Lactoferrin H & Minocycline; Minocycline [USAN:INN:BAN]; Minomycin;; SR-05000001675; (minocycline); Minoderm;; Aknemin;; Arestin;; Dynacin;; Minocin;; Sebomin;; Solodyn;; Akamin;; (4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2- CARBOXAMIDE; (4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide; NSC141993; Spectrum_000967; MINOCYCLINE [MI]; Prestwick0_000315; Prestwick1_000315; Prestwick2_000315; Spectrum2_001047; Spectrum3_000508; Spectrum4_000062; Spectrum5_001293; MINOCYCLINE [INN]; MINOCYCLINE [HSDB]; MINOCYCLINE [USAN]; MINOCYCLINE [VANDF]; SCHEMBL4042; CHEMBL1434; MINOCYCLINE [MART.]; SCHEMBL24315; BSPBio_002035; KBioGR_000583; KBioSS_001447; MINOCYCLINE [WHO-DD]; 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S-(4alpha,4aalpha,5aalpha,12aalpha))-; DivK1c_000450; SPBio_000974; SPBio_002529; orb1989822; DTXCID9025033; SCHEMBL16681149; SCHEMBL29369923; SCHEMBL29416350; BCBcMAP01_000027; GTPL10831; KBio1_000450; KBio2_001447; KBio2_004015; KBio2_006583; KBio3_001535; NINDS_000450; HMS2090D03; KUC106429N; (4S,4aS,5aR,12aS)4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxonaphthacene-2-carboxamide;(4S,4aS,5aR,12aS)4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxonaphthacene-2-carboxamide; 2-NAPHTHACENECARBOXAMIDE, 4,7-BIS(DIMETHYLAMINO)-1,4,4A,5,5A,6,11,12A-OCTAHYDRO-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-, (4S-(4.ALPHA.,4A.ALPHA.,5A.ALPHA.,12A.ALPHA.))-; KSC-12-231B; Tox21_113643; BDBM50103599; EBC-27149; HY-17412A; LMPK07000002; AKOS015969674; CL59806; DB01017; Minocycline; Tigecycline EP Impurity C; IDI1_000450; SMP1_000191; NCGC00178854-01; NCGC00178854-02; NCGC00188954-01; NCGC00482890-01; AC-30184; CL-59806; DA-65471; SBI-0051449.P003; CAS-10118-90-8; CS-0009521; NS00007904; TIGECYCLINE IMPURITY C [EP IMPURITY]; C07225; D05045; D78303; AB00053501-03; AB00053501_04; AB00053501_05; EN300-7481098; Q415336; T131626; SR-05000001675-3; (4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-Synonyme
Produkte, die Minocycline enthalten
Unternehmen, die Minocycline verkaufen
CT
Công ty cổ phần dược phẩm WealpharViet NamSP
STARWAY PHARM Co., Ltd.ChinaCT
Công ty TNHH dược phẩm Huy VănViet NamCT
Công ty cổ phần dược mỹ phẩm Bảo AnViet NamCT
Công ty cổ phần dược phẩm Phúc LongViet NamCT
Công ty TNHH Dược phẩm LamdaViet Nam